Literature DB >> 22297838

Review of HPLC methods and HPLC methods with mass spectrometric detection for direct determination of aspirin with its metabolite(s) in various biological matrices.

Ramesh Mullangi1, Kuldeep Sharma, Nuggehally R Srinivas.   

Abstract

Aspirin, the most widely used drug in the world, has been known to mankind for over a century. It is not only the pharmacologically active entity, but is also biotransformed into a major metabolite, i.e. salicylic acid, which also exhibits similar pharmacologic/pharmacodynamic properties. Hence it is necessary to quantitate aspirin along with its metabolite(s) in various biological matrices accurately and precisely to correlate with pharmacological/pharmacodynamic activity. This paper provides a comprehensive overview of various bioanalytical methods (HPLC and LC-MS/MS) that have been reported for direct quantitation of aspirin along with its metabolite(s). The review also provides general information on sample collection, sample processing, internal standard selection, conditions for chromatographic separation, succinct validation data and applicable conclusions for reported assays in a structured manner.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297838     DOI: 10.1002/bmc.2694

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage.

Authors:  Nwanneka Okwundu; Hafeez Rahman; Tong Liu; Scott R Florell; Kenneth M Boucher; Douglas Grossman
Journal:  Cancer Prev Res (Phila)       Date:  2021-11-08

2.  Separation of Aliphatic and Aromatic Carboxylic Acids by Conventional and Ultra High Performance Ion Exclusion Chromatography.

Authors:  Fotouh R Mansour; Christine L Kirkpatrick; Neil D Danielson
Journal:  Chromatographia       Date:  2013-06       Impact factor: 2.044

3.  ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma.

Authors:  Amir Varedi; Hafeez Rahman; Dileep Kumar; Jonathan L Catrow; James E Cox; Tong Liu; Scott R Florell; Kenneth M Boucher; Nwanneka Okwundu; William J Burnett; Matthew W VanBrocklin; Douglas Grossman
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.